These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8138240)

  • 1. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
    Kitani K; Kanai S; Sato Y; Ohta M
    Hepatology; 1994 Apr; 19(4):1007-12. PubMed ID: 8138240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content.
    Ohiwa T; Katagiri K; Hoshino M; Hayakawa T; Nakai T
    Hepatology; 1993 Mar; 17(3):470-6. PubMed ID: 8383089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of hydrophilic bile acids on bile acid hepatotoxicity in the rat.
    Kitani K
    Ital J Gastroenterol; 1995 Sep; 27(7):366-71. PubMed ID: 8563008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauro alpha-muricholate has a biliary transport maximum (Tm) value equivalent to that for tauroursodeoxycholate and tauro beta-muricholate in the rat.
    Kanai S; Kitani K; Ohta M; Sato Y
    Life Sci; 1994; 54(7):499-505. PubMed ID: 8309352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats.
    Takikawa H; Sano N; Aiso M; Takamori Y; Yamanaka M
    J Gastroenterol Hepatol; 1997 Jan; 12(1):84-6. PubMed ID: 9076630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauro beta-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.
    Kanai S; Ohta M; Kitani K; Sato Y
    Life Sci; 1990; 47(26):2421-8. PubMed ID: 2263167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurine conjugate of 3 alpha,6 beta,7 beta-trihydroxy-5 beta,22-cholen-24-oic acid (tauro-delta 22-beta-muricholate): the major bile acid in the serum of female rats treated with alpha-naphthylisothiocyanate and its secretion by liver slices.
    Thompson MB; Davis DG; Morris RW
    J Lipid Res; 1993 Apr; 34(4):553-61. PubMed ID: 8496661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary albumin excretion induced by bile salts in rats is a pathological phenomenon.
    Ohta M; Kitani K; Kanai S
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):373-88. PubMed ID: 2813958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monohydroxy bile salt sulfates: tauro-3 beta-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats.
    Mathis U; Karlaganis G; Preisig R
    Gastroenterology; 1983 Sep; 85(3):674-81. PubMed ID: 6873614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
    Roda A; Piazza F; Baraldini M; Speroni E; Guerra MC; Cerré C; Cantelli Forti G
    Hepatology; 1998 Feb; 27(2):520-5. PubMed ID: 9462652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat.
    Kitani K; Ohta M; Kanai S
    Am J Physiol; 1985 Apr; 248(4 Pt 1):G407-17. PubMed ID: 2984943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoursodeoxycholate is as effective as tauroursodeoxycholate in preventing the taurocholate-induced cholestasis in the rat.
    Kanai S; Kitani K
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):423-30. PubMed ID: 6665300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation with taurine prevents side-chain desaturation of ursodeoxycholic and beta-muricholic acids in bile fistula rats.
    Guitaoui M; Parquet M; Aubert C; Montet AM; Montet JC
    Fundam Clin Pharmacol; 2004 Aug; 18(4):457-64. PubMed ID: 15312152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic injury induced by bile salts: correlation between biochemical and morphological events.
    Schmucker DL; Ohta M; Kanai S; Sato Y; Kitani K
    Hepatology; 1990 Nov; 12(5):1216-21. PubMed ID: 2227821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
    Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
    Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
    Kanai S; Kitani K; Sato Y
    Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between different bile salts in the biliary excretion of the rat.
    Kitani K; Kanai S
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):139-52. PubMed ID: 6844732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transport of bile acid and effect of conjugation.
    Kitani K
    Ital J Gastroenterol; 1995 Jun; 27(5):270-6. PubMed ID: 8541581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
    Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
    Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics and structure of inclusion compounds of tauro- and glyco-conjugated bile salts and beta-cyclodextrin.
    Holm R; Shi W; Hartvig RA; Askjaer S; Christian Madsen J; Westh P
    Phys Chem Chem Phys; 2009 Jul; 11(25):5070-8. PubMed ID: 19562137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.